WC
AGN

Wexford Capital’s Allergan Inc AGN Stock Holding History

Wexford Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-5,200
Closed -$927K – 124
2014
Q3 		$927K Buy
+5,200
New +$864K 0.09% 84

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Wexford Capital's AGN Position: Q4 2014 in Review

Wexford Capital sold out of Allergan Inc (AGN) in Q4 2014, closing a stake of 10,000 shares — an estimated $1.78M sold.

Wexford Capital first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $11.7M in Q1 2014. 819 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • Wexford Capital reported no remaining Allergan Inc position as of Q4 2014 after selling out during the quarter.
  • Wexford Capital sold 10,000 Allergan Inc shares in Q4 2014, an estimated $1.78M.
  • Wexford Capital first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • Wexford Capital's Allergan Inc position peaked at $11.7M in Q1 2014.
  • 819 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2014.

Based on Wexford Capital's 13F filing for Q4 2014, filed 13 Feb 2015.